Abstract
Transdermal therapeutic systems (TTSs) are commonly used to treat many diverse medical conditions. There are several advantages to this form of drug delivery; however, adverse cutaneous reactions are common. This review article provides an update on skin reactions due to TTSs containing medications newly available in TTS form, including buprenorphine, diclofenac, lidocaine, oxybutynin, rotigotine, methylphenidate, rivastigmine, teriparatide, and nicardipine.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 193-203 |
| Number of pages | 11 |
| Journal | Dermatitis |
| Volume | 22 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2011 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Cutaneous reactions to transdermal therapeutic systems'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS